Share
Journal Information
Issue
Vol. 16. Issue 5.Pages 696-821 (September - October 2017)
Editorial
Blue-Print for Elimination of Hepatitis C Viral Infection: One Step Closer
Kevork M. Peltekian
Ann Hepatol. 2017;16:696-8
Open access
Waiting-Time and Quality of Care Deserved to Patients with Early Stage Hepatocellular Carcinoma Undergoing RFA Treatment
Maurizio Soresi, Anna Licata, Lydia Giannitrapani, Giuseppe Montalto
Ann Hepatol. 2017;16:699-701
Open access
Opinions
Transplanting Kidney Allografts from Hepatitis C Infected Donors into Hepatitis C Uninfected Recipients: Re-Thinking the Thinker Trial
Trana Hussaini, Eric M. Yoshida
Ann Hepatol. 2017;16:702-3
Open access
Viewpoint
Fibrates for Primary Biliary Cholangitis: What’s All the Hype?
Cynthia Levy
Ann Hepatol. 2017;16:704-6
Open access
Concise review
Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine
Elena Grasselli, Laura Canesi, Piero Portincasa, Adriana Voci, Laura Vergani, Ilaria Demori
Ann Hepatol. 2017;16:707-19
Open access
Original article
Hepatitis C Virus Infection Outcomes Among Immigrants to Canada: A Retrospective Cohort Analysis
Curtis L. Cooper, Kednapa Thavorn, Ecaterina Damian, Daniel J. Corsi
Ann Hepatol. 2017;16:720-6
Open access
Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil
Hoel Sette-Jr, Hugo Cheinquer, Fernando H. Wolff, Alexandre de Araujo, Silvia Coelho-Borges, Silvia R.P. Soares, Mauricio F.A. Barros
Ann Hepatol. 2017;16:727-33
Open access
Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination
Akihiro Tamori, Hoang Hai, Sawako Uchida-Kobayashi, Masaru Enomoto, Ritsuzo Kozuka, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, ... Norifumi Kawada
Ann Hepatol. 2017;16:734-41
Open access
Effect of Vitamin D Serum Levels and GC Gene Polymorphisms in Liver Fibrosis Due to Chronic Hepatitis C
Laura A. Azevedo, Ursula Matte, Themis R. Silveira, Jacqueline W. Bonfanti, Juliana P. Bruch, Mário R. Álvares-da-Silva
Ann Hepatol. 2017;16:742-8
Open access
Early Successes in an Open Access, Provincially Funded Hepatitis C Treatment Program in Prince Edward Island
Jordan W. Francheville, Robin Rankin, Jeremy Beck, Connie Hoare, Stefanie Materniak, Greg German, Lisa Barrett, Natalie Bunimov-Wall, Daniel Smyth
Ann Hepatol. 2017;16:749-58
Open access
The Histopathological Features and CT/MRI Imaging Performances in Hepatic Angiomyolipoma Patients
Hongtao Wei, Hui Liu, Yuhan Chen, Xiaowei Xue, Honglei Weng, Huiguo Ding
Ann Hepatol. 2017;16:759-64
Open access
Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular Carcinoma
Mayur Brahmania, Osman Ahmed, Melissa Kelley, Matthew Kowgier, Korosh Khalili, Rob Beecroft, Eberhard L. Renner, David Wong, ... Morris Sherman
Ann Hepatol. 2017;16:765-71
Open access
Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients
Roberto Candia, Blanca Norero, Carlos Agüero, Luis Díaz, Juan Pablo Ortega, Rodrigo Wolff, Cristian Hernández-Rocha, Ignacio Duarte, ... Marco Arrese
Ann Hepatol. 2017;16:772-9
Open access
Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis
Jéssica G. Pereira, Telma Erotides Silva, Emília T.O. Bansho, Edelton F. Morato, José T. Pinheiro, Letícia Muraro-Wildner, Maria Luiza Bazzo, Esther Buzaglo Dantas-Corrêa, ... Janaína L. Narciso-Schiavon
Ann Hepatol. 2017;16:780-7
Open access
Algorithm for Screening of Adrenal Function in Stable Patients with Cirrhosis
Jonathan Paz-Delgadillo, Roberto Monreal-Robles, Jesús Z. Villarreal-Pérez, Fernando J. Lavalle-González, Héctor J. Maldonado-Garza, Francisco J. Bosques-Padilla
Ann Hepatol. 2017;16:788-96
Open access
Clinical Characteristics and Complications of Pediatric Liver Biopsy: A Single Centre Experience
Patricia Almeida, Richard A. Schreiber, Jennifer Liang, Quais Mujawar, Orlee R. Guttman
Ann Hepatol. 2017;16:797-801
Open access
Clinical and Laboratory Associations with Persistent Hyperferritinemia in 373 Black Hemochromatosis and Iron Overload Screening Study Participants
James C. Barton, J. Clayborn Barton, Paul C. Adams
Ann Hepatol. 2017;16:802-11
Open access
Multiple Biliary Hamartomas, The ‘‘Von Meyenburg Complexes’’
Joel O. Jáquez-Quintana, Erick A. Reyes-Cabello, Francisco J. Bosques-Padilla
Ann Hepatol. 2017;16:812-3
Open access
Case report
Monosegmental ALPPS after Bilateral Hepatectomy
Klaus Steinbrück, Marcelo D’Oliveira, Renato Cano, Marcelo Enne
Ann Hepatol. 2017;16:814-7
Open access
Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment
Sunil Taneja, Pramod Kumar, Sahaj Rathi, Ajay Duseja, Virendra Singh, Radha Krishan Dhiman, Yogesh Kumar Chawla
Ann Hepatol. 2017;16:818-21
Open access
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
